Creative Planning
PRQR icon

Creative Planning’s ProQR Therapeutics PRQR Stock Holding History

Creative Planning’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,900
Closed -$10K – 3245
2017
Q2 		$10K Hold
1,900
– – ﹤0.01% 3632
2017
Q1 		$10K Hold
1,900
– – ﹤0.01% 3601
2016
Q4 		$9K Buy
1,900
+1,500
+375% +$7.73K ﹤0.01% 3620
2016
Q3 		$3K Sell
400
-1,100
-73% -$6.05K ﹤0.01% 4119
2016
Q2 		$7K Buy
1,500
+1,100
+275% +$5.66K ﹤0.01% 3476
2016
Q1 		$2K Hold
400
– – ﹤0.01% 3976
2015
Q4 		$3K Hold
400
– – ﹤0.01% 3921
2015
Q3 		$6K Buy
+400
New +$6.7K ﹤0.01% 3523

Other funds holding PRQR

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Creative Planning's PRQR Position: Q3 2017 in Review

Creative Planning sold out of ProQR Therapeutics (PRQR) in Q3 2017, closing a stake of 1,900 shares — an estimated $10K sold.

Creative Planning first reported a position in PRQR in Q3 2015 and held it in 8 quarters. The position peaked at $10K in Q2 2017. 23 funds tracked by Wall St. Rank hold PRQR as of Q3 2017.

  • Creative Planning reported no remaining ProQR Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 1,900 ProQR Therapeutics shares in Q3 2017, an estimated $10K.
  • Creative Planning first reported a position in ProQR Therapeutics in Q3 2015 and held it in 8 quarters.
  • Creative Planning's ProQR Therapeutics position peaked at $10K in Q2 2017.
  • 23 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.